{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:23:36Z","timestamp":1795087416604,"version":"4.10.2"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005867","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:17:32Z","timestamp":1785943052000},"page":"e2340-e2345","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["How I Do It: Hepatitis B Virus in Kidney Transplantation"],"prefix":"10.1097","volume":"110","author":[{"given":"Desmond Y. H.","family":"Yap","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lung-Yi","family":"Mak","sequence":"additional","affiliation":[{"name":"Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung College of Medicine, Kaosiung, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Hui","family":"Hu","sequence":"additional","affiliation":[{"name":"Division of Hepatology and Gastroenterology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"R1-20261119","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3851\/IMP2097","article-title":"A novel experience of antiviral therapy for chronic hepatitis B in renal transplant recipients.","volume":"17","author":"Hu","year":"2012","journal-title":"Antivir Ther"},{"key":"R2-20261119","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/TP.0b013e3181e5b811","article-title":"Long-term outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments.","volume":"90","author":"Yap","year":"2010","journal-title":"Transplantation"},{"key":"R3-20261119","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/ctr.12410","article-title":"Entecavir treatment in kidney transplant recipients infected with hepatitis B.","volume":"28","author":"Yap","year":"2014","journal-title":"Clin Transplant"},{"key":"R4-20261119","doi-asserted-by":"crossref","first-page":"100833","DOI":"10.1016\/j.bj.2025.100833","article-title":"A long term bone and renal safety of TAF treatment on renal transplant recipients.","volume":"48","author":"Yap","year":"2025","journal-title":"Biomed J"},{"key":"R5-20261119","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL clinical practice guidelines on the management of hepatitis B virus infection.","volume":"83","year":"2025","journal-title":"J Hepatol"},{"key":"R6-20261119","doi-asserted-by":"crossref","first-page":"e13514","DOI":"10.1111\/ctr.13514","article-title":"Viral hepatitis: guidelines by the American Society of Transplantation Infectious Disease Community of Practice.","volume":"33","author":"Te","year":"2019","journal-title":"Clin Transplant"},{"key":"R7-20261119","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/j.1600-6143.2009.02707.x","article-title":"Kidney transplantation from hepatitis B surface antigen positive donors into hepatitis B surface antibody positive recipients: a prospective nonrandomized controlled study from a single center.","volume":"9","author":"Jiang","year":"2009","journal-title":"Am J Transplant"},{"key":"R8-20261119","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood.V96.2.452.014k13_452_458","article-title":"A case-controlled study on the use of HBsAg-positive donors for allogeneic hematopoietic cell transplantation.","volume":"96","author":"Lau","year":"2000","journal-title":"Blood"},{"key":"R9-20261119","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.gastro.2024.11.008","article-title":"AGA clinical practice guideline on the prevention and treatment of hepatitis B virus reactivation in At-Risk individuals.","volume":"168","author":"Ali","year":"2025","journal-title":"Gastroenterology"},{"key":"R10-20261119","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis.","volume":"63","year":"2015","journal-title":"J Hepatol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:00:15Z","timestamp":1795086015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005867","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"2025-11-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}